Global Viral Conjunctivitis Drugs Market Research Report 2023

Report ID: 1992869 | Published Date: Jan 2025 | No. of Page: 85 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Viral Conjunctivitis Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 FST-100
        1.2.3 APD-209
    1.3 Market by Application
        1.3.1 Global Viral Conjunctivitis Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 ASCs
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Viral Conjunctivitis Drugs Market Perspective (2017-2028)
    2.2 Viral Conjunctivitis Drugs Growth Trends by Region
        2.2.1 Viral Conjunctivitis Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Viral Conjunctivitis Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Viral Conjunctivitis Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Viral Conjunctivitis Drugs Market Dynamics
        2.3.1 Viral Conjunctivitis Drugs Industry Trends
        2.3.2 Viral Conjunctivitis Drugs Market Drivers
        2.3.3 Viral Conjunctivitis Drugs Market Challenges
        2.3.4 Viral Conjunctivitis Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Viral Conjunctivitis Drugs Players by Revenue
        3.1.1 Global Top Viral Conjunctivitis Drugs Players by Revenue (2017-2022)
        3.1.2 Global Viral Conjunctivitis Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Viral Conjunctivitis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Viral Conjunctivitis Drugs Revenue
    3.4 Global Viral Conjunctivitis Drugs Market Concentration Ratio
        3.4.1 Global Viral Conjunctivitis Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Viral Conjunctivitis Drugs Revenue in 2021
    3.5 Viral Conjunctivitis Drugs Key Players Head office and Area Served
    3.6 Key Players Viral Conjunctivitis Drugs Product Solution and Service
    3.7 Date of Enter into Viral Conjunctivitis Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Conjunctivitis Drugs Breakdown Data by Type
    4.1 Global Viral Conjunctivitis Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Viral Conjunctivitis Drugs Forecasted Market Size by Type (2023-2028)
5 Viral Conjunctivitis Drugs Breakdown Data by Application
    5.1 Global Viral Conjunctivitis Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Viral Conjunctivitis Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Viral Conjunctivitis Drugs Market Size (2017-2028)
    6.2 North America Viral Conjunctivitis Drugs Market Size by Country (2017-2022)
    6.3 North America Viral Conjunctivitis Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Viral Conjunctivitis Drugs Market Size (2017-2028)
    7.2 Europe Viral Conjunctivitis Drugs Market Size by Country (2017-2022)
    7.3 Europe Viral Conjunctivitis Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Viral Conjunctivitis Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Viral Conjunctivitis Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Viral Conjunctivitis Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Viral Conjunctivitis Drugs Market Size (2017-2028)
    9.2 Latin America Viral Conjunctivitis Drugs Market Size by Country (2017-2022)
    9.3 Latin America Viral Conjunctivitis Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Viral Conjunctivitis Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Viral Conjunctivitis Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Viral Conjunctivitis Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Adenovir Pharma
        11.1.1 Adenovir Pharma Company Detail
        11.1.2 Adenovir Pharma Business Overview
        11.1.3 Adenovir Pharma Viral Conjunctivitis Drugs Introduction
        11.1.4 Adenovir Pharma Revenue in Viral Conjunctivitis Drugs Business (2017-2022)
        11.1.5 Adenovir Pharma Recent Development
    11.2 Allergan
        11.2.1 Allergan Company Detail
        11.2.2 Allergan Business Overview
        11.2.3 Allergan Viral Conjunctivitis Drugs Introduction
        11.2.4 Allergan Revenue in Viral Conjunctivitis Drugs Business (2017-2022)
        11.2.5 Allergan Recent Development
    11.3 NanoViricides
        11.3.1 NanoViricides Company Detail
        11.3.2 NanoViricides Business Overview
        11.3.3 NanoViricides Viral Conjunctivitis Drugs Introduction
        11.3.4 NanoViricides Revenue in Viral Conjunctivitis Drugs Business (2017-2022)
        11.3.5 NanoViricides Recent Development
    11.4 Takeda
        11.4.1 Takeda Company Detail
        11.4.2 Takeda Business Overview
        11.4.3 Takeda Viral Conjunctivitis Drugs Introduction
        11.4.4 Takeda Revenue in Viral Conjunctivitis Drugs Business (2017-2022)
        11.4.5 Takeda Recent Development
    11.5 NovaBay Pharmaceuticals
        11.5.1 NovaBay Pharmaceuticals Company Detail
        11.5.2 NovaBay Pharmaceuticals Business Overview
        11.5.3 NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Introduction
        11.5.4 NovaBay Pharmaceuticals Revenue in Viral Conjunctivitis Drugs Business (2017-2022)
        11.5.5 NovaBay Pharmaceuticals Recent Development
    11.6 Novartis
        11.6.1 Novartis Company Detail
        11.6.2 Novartis Business Overview
        11.6.3 Novartis Viral Conjunctivitis Drugs Introduction
        11.6.4 Novartis Revenue in Viral Conjunctivitis Drugs Business (2017-2022)
        11.6.5 Novartis Recent Development
    11.7 Panoptes Pharma
        11.7.1 Panoptes Pharma Company Detail
        11.7.2 Panoptes Pharma Business Overview
        11.7.3 Panoptes Pharma Viral Conjunctivitis Drugs Introduction
        11.7.4 Panoptes Pharma Revenue in Viral Conjunctivitis Drugs Business (2017-2022)
        11.7.5 Panoptes Pharma Recent Development
    11.8 NicOx
        11.8.1 NicOx Company Detail
        11.8.2 NicOx Business Overview
        11.8.3 NicOx Viral Conjunctivitis Drugs Introduction
        11.8.4 NicOx Revenue in Viral Conjunctivitis Drugs Business (2017-2022)
        11.8.5 NicOx Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Viral Conjunctivitis Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of FST-100
    Table 3. Key Players of APD-209
    Table 4. Global Viral Conjunctivitis Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Viral Conjunctivitis Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Viral Conjunctivitis Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Viral Conjunctivitis Drugs Market Share by Region (2017-2022)
    Table 8. Global Viral Conjunctivitis Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Viral Conjunctivitis Drugs Market Share by Region (2023-2028)
    Table 10. Viral Conjunctivitis Drugs Market Trends
    Table 11. Viral Conjunctivitis Drugs Market Drivers
    Table 12. Viral Conjunctivitis Drugs Market Challenges
    Table 13. Viral Conjunctivitis Drugs Market Restraints
    Table 14. Global Viral Conjunctivitis Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Viral Conjunctivitis Drugs Market Share by Players (2017-2022)
    Table 16. Global Top Viral Conjunctivitis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Conjunctivitis Drugs as of 2021)
    Table 17. Ranking of Global Top Viral Conjunctivitis Drugs Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Viral Conjunctivitis Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Viral Conjunctivitis Drugs Product Solution and Service
    Table 21. Date of Enter into Viral Conjunctivitis Drugs Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Viral Conjunctivitis Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Viral Conjunctivitis Drugs Revenue Market Share by Type (2017-2022)
    Table 25. Global Viral Conjunctivitis Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Viral Conjunctivitis Drugs Revenue Market Share by Type (2023-2028)
    Table 27. Global Viral Conjunctivitis Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Viral Conjunctivitis Drugs Revenue Market Share by Application (2017-2022)
    Table 29. Global Viral Conjunctivitis Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Viral Conjunctivitis Drugs Revenue Market Share by Application (2023-2028)
    Table 31. North America Viral Conjunctivitis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Viral Conjunctivitis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Viral Conjunctivitis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Viral Conjunctivitis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Viral Conjunctivitis Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Viral Conjunctivitis Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Viral Conjunctivitis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Viral Conjunctivitis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Viral Conjunctivitis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Viral Conjunctivitis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Adenovir Pharma Company Detail
    Table 42. Adenovir Pharma Business Overview
    Table 43. Adenovir Pharma Viral Conjunctivitis Drugs Product
    Table 44. Adenovir Pharma Revenue in Viral Conjunctivitis Drugs Business (2017-2022) & (US$ Million)
    Table 45. Adenovir Pharma Recent Development
    Table 46. Allergan Company Detail
    Table 47. Allergan Business Overview
    Table 48. Allergan Viral Conjunctivitis Drugs Product
    Table 49. Allergan Revenue in Viral Conjunctivitis Drugs Business (2017-2022) & (US$ Million)
    Table 50. Allergan Recent Development
    Table 51. NanoViricides Company Detail
    Table 52. NanoViricides Business Overview
    Table 53. NanoViricides Viral Conjunctivitis Drugs Product
    Table 54. NanoViricides Revenue in Viral Conjunctivitis Drugs Business (2017-2022) & (US$ Million)
    Table 55. NanoViricides Recent Development
    Table 56. Takeda Company Detail
    Table 57. Takeda Business Overview
    Table 58. Takeda Viral Conjunctivitis Drugs Product
    Table 59. Takeda Revenue in Viral Conjunctivitis Drugs Business (2017-2022) & (US$ Million)
    Table 60. Takeda Recent Development
    Table 61. NovaBay Pharmaceuticals Company Detail
    Table 62. NovaBay Pharmaceuticals Business Overview
    Table 63. NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Product
    Table 64. NovaBay Pharmaceuticals Revenue in Viral Conjunctivitis Drugs Business (2017-2022) & (US$ Million)
    Table 65. NovaBay Pharmaceuticals Recent Development
    Table 66. Novartis Company Detail
    Table 67. Novartis Business Overview
    Table 68. Novartis Viral Conjunctivitis Drugs Product
    Table 69. Novartis Revenue in Viral Conjunctivitis Drugs Business (2017-2022) & (US$ Million)
    Table 70. Novartis Recent Development
    Table 71. Panoptes Pharma Company Detail
    Table 72. Panoptes Pharma Business Overview
    Table 73. Panoptes Pharma Viral Conjunctivitis Drugs Product
    Table 74. Panoptes Pharma Revenue in Viral Conjunctivitis Drugs Business (2017-2022) & (US$ Million)
    Table 75. Panoptes Pharma Recent Development
    Table 76. NicOx Company Detail
    Table 77. NicOx Business Overview
    Table 78. NicOx Viral Conjunctivitis Drugs Product
    Table 79. NicOx Revenue in Viral Conjunctivitis Drugs Business (2017-2022) & (US$ Million)
    Table 80. NicOx Recent Development
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Viral Conjunctivitis Drugs Market Share by Type: 2021 VS 2028
    Figure 2. FST-100 Features
    Figure 3. APD-209 Features
    Figure 4. Global Viral Conjunctivitis Drugs Market Share by Application in 2021 & 2028
    Figure 5. Hospitals Case Studies
    Figure 6. ASCs Case Studies
    Figure 7. Others Case Studies
    Figure 8. Viral Conjunctivitis Drugs Report Years Considered
    Figure 9. Global Viral Conjunctivitis Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Viral Conjunctivitis Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Viral Conjunctivitis Drugs Market Share by Region: 2021 VS 2028
    Figure 12. Global Viral Conjunctivitis Drugs Market Share by Players in 2021
    Figure 13. Global Top Viral Conjunctivitis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Conjunctivitis Drugs as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Viral Conjunctivitis Drugs Revenue in 2021
    Figure 15. North America Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Viral Conjunctivitis Drugs Market Share by Country (2017-2028)
    Figure 17. United States Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Viral Conjunctivitis Drugs Market Share by Country (2017-2028)
    Figure 21. Germany Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Viral Conjunctivitis Drugs Market Share by Region (2017-2028)
    Figure 29. China Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Viral Conjunctivitis Drugs Market Share by Country (2017-2028)
    Figure 37. Mexico Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Viral Conjunctivitis Drugs Market Share by Country (2017-2028)
    Figure 41. Turkey Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Viral Conjunctivitis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Adenovir Pharma Revenue Growth Rate in Viral Conjunctivitis Drugs Business (2017-2022)
    Figure 44. Allergan Revenue Growth Rate in Viral Conjunctivitis Drugs Business (2017-2022)
    Figure 45. NanoViricides Revenue Growth Rate in Viral Conjunctivitis Drugs Business (2017-2022)
    Figure 46. Takeda Revenue Growth Rate in Viral Conjunctivitis Drugs Business (2017-2022)
    Figure 47. NovaBay Pharmaceuticals Revenue Growth Rate in Viral Conjunctivitis Drugs Business (2017-2022)
    Figure 48. Novartis Revenue Growth Rate in Viral Conjunctivitis Drugs Business (2017-2022)
    Figure 49. Panoptes Pharma Revenue Growth Rate in Viral Conjunctivitis Drugs Business (2017-2022)
    Figure 50. NicOx Revenue Growth Rate in Viral Conjunctivitis Drugs Business (2017-2022)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Adenovir Pharma
Allergan
NanoViricides
Takeda
NovaBay Pharmaceuticals
Novartis
Panoptes Pharma
NicOx
Frequently Asked Questions
Viral Conjunctivitis Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Viral Conjunctivitis Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Viral Conjunctivitis Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Virtual Assistant

Virtual Assistant market is segmented by players, region (country), by Medium and by Application. ... Read More